Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities

Rhea-AI Summary

Clarivate (NYSE: CLVT) announced that subsidiary Camelot Finance S.A. fully redeemed the remaining $100 million aggregate principal of its 4.50% senior secured notes due 2026 on Jan 30, 2026, paying 100% of principal plus accrued interest.

The redemption was funded with cash on hand and is part of Clarivate's capital allocation strategy, which also included repurchasing ~56 million ordinary shares for $225 million in 2025 (including ~21 million shares for $75 million in Q4 2025).

Positive

• Full redemption of $100 million 2026 secured notes completed on Jan 30, 2026
• Share repurchases of 56 million ordinary shares for $225 million in 2025
• Redemption funded with cash on hand, improving financial flexibility

Negative

• Repurchases of $225 million reduced cash reserves available for other uses

Key Figures

Redeemed notes principal: $100 million Coupon rate: 4.50% Redemption price: 100% of principal + interest +5 more

8 metrics

Redeemed notes principal $100 million Remaining 4.50% senior secured notes due 2026, redeemed Jan 30, 2026

Coupon rate 4.50% Senior secured notes due 2026 originally issued Oct 31, 2019

Redemption price 100% of principal + interest Cash redemption of remaining 2026 notes on Jan 30, 2026

Q4 2025 buybacks ≈21 million shares / $75 million Ordinary shares repurchased during Q4 2025

2025 full-year buybacks ≈56 million shares / $225 million Ordinary shares repurchased during full year 2025

Shares outstanding 661,435,069 shares Outstanding as of Sep 30, 2025 per S-3ASR summary

Registered resale shares 245,076,317 shares Ordinary shares registered for resale under Form S-3 shelf

Market cap pre-news $1,785,874,686 Based on price of $2.65 before this announcement

Market Reality Check

Price: $2.65 Vol: Volume 5,290,422 is 2% ab...

normal vol

$2.65 Last Close

Volume Volume 5,290,422 is 2% above the 20-day average of 5,203,595, indicating typical trading interest before this news. normal

Technical Shares at $2.65 are trading below the 200-day MA of $3.86 and about 53% under the $5.63 52-week high, hovering just above the $2.5911 52-week low.

Peers on Argus

CLVT was down 1.85% ahead of this news. Sector peers in the momentum scan, inclu...

2 Down

CLVT was down 1.85% ahead of this news. Sector peers in the momentum scan, including VNET and APLD, were also moving down (median about -4.4%), suggesting broader pressure across related names rather than a purely idiosyncratic move.

Historical Context

5 past events · Latest: Jan 28 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 28	Earnings date notice	Neutral	-4.2%	Announcement of upcoming Q4 and full-year 2025 earnings release and call.
Jan 22	AI product launch	Positive	+3.6%	Launch of Clarivate Nexus academic assistant integrating trusted resources into AI tools.
Jan 21	Research report	Neutral	-3.8%	Publication of Top 100 Global Innovators 2026 highlighting leading invention activity.
Jan 15	Peer AI update	Positive	+0.6%	MongoDB announcement of expanded AI capabilities and Voyage 4 model integrations.
Jan 06	Sector insights report	Neutral	+0.0%	Release of Drugs to Watch 2026 report naming eleven potential blockbuster therapies.

Pattern Detected

Recent CLVT headlines have often seen mixed reactions, with some neutral news followed by notable downside while product-related AI announcements drew modest gains.

Recent Company History

Over the past month, Clarivate has issued several informational and product-focused updates. An AI product launch on Jan 22, 2026 coincided with a +3.56% move, while neutral reports such as the Top 100 Global Innovators list on Jan 21, 2026 and an earnings date notice on Jan 28, 2026 saw declines of -3.77% and -4.2%. Earlier, the Drugs to Watch 2026 report on Jan 6, 2026 had no price impact. Against this backdrop, the new debt redemption and buyback update adds a balance-sheet focused milestone to a stream of mainly informational releases.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-11-04

Clarivate has an active automatic shelf registration on Form S-3ASR filed on Nov 4, 2025, allowing potential primary offerings of various securities and the resale of up to 245,076,317 ordinary shares by existing holders. The company would not receive proceeds from selling-shareholder resales, while any primary issuance proceeds would be for general corporate purposes.

Market Pulse Summary

This announcement centers on debt reduction and capital returns. Clarivate fully redeemed its remain...

Analysis

This announcement centers on debt reduction and capital returns. Clarivate fully redeemed its remaining $100 million 4.50% senior secured notes due 2026 with cash on hand and repurchased about 56 million shares for $225 million during 2025. These actions follow a series of informational and product updates in January 2026 with mixed price reactions. Investors may monitor future filings and earnings commentary for clarity on ongoing leverage targets, buyback pace, and how these moves interact with the existing S-3ASR shelf capacity.

Key Terms

senior secured notes

1 terms

senior secured notes financial

"has redeemed the remaining $100 million aggregate principal amount of its 4.50% senior secured notes due 2026"

Senior secured notes are loans a company sells to investors that are backed by specific assets and given first priority for repayment if the company defaults. Because they have a claim on collateral and are paid before other debts, they usually offer lower risk and correspondingly lower interest than unsecured debt; investors use them to judge how safe repayment and recovery of principal might be, like holding a mortgage instead of an unsecured credit card balance.

AI-generated analysis. Not financial advice.

LONDON, Feb. 2, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that its subsidiary, Camelot Finance S.A., has redeemed the remaining $100 million aggregate principal amount of its 4.50% senior secured notes due 2026, originally issued on October 31, 2019 (the "2026 Notes").

The 2026 Notes were redeemed on January 30, 2026 (the "Redemption Date") at a cash redemption price equal to 100% of the remaining principal amount, or $100 million, plus accrued and unpaid interest through the Redemption Date. With this transaction, the 2026 Notes have now been fully redeemed.

This redemption was funded with cash on hand and is consistent with Clarivate's ongoing efforts to simplify its capital structure, reduce debt, and enhance financial flexibility.

As part of its broader capital allocation strategy, Clarivate also announced that it repurchased approximately 21 million ordinary shares for $75 million during the fourth quarter of 2025. For the full year of 2025, Clarivate repurchased approximately 56 million ordinary shares for $225 million. These share repurchases reflect Clarivate's disciplined approach to returning capital to shareholders while investing for long‑term growth.

"The full redemption of our remaining 2026 Notes, combined with our share repurchase activity throughout 2025, reflects the continued execution of our disciplined capital allocation strategy," said Jonathan Collins, Executive Vice President and Chief Financial Officer. "We remain focused on strengthening our balance sheet, enhancing financial flexibility, and driving long‑term value creation for our shareholders."

Forward-Looking Statements
This release includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements" within the meaning of the "safe harbor provisions" of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "seeks," "projects," "intends," "plans," "may," "will," or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts, and include statements regarding our intentions, beliefs, or current expectations concerning, among other things, anticipated cost savings, results of operations, financial condition, liquidity, prospects, growth, strategies, and the markets in which we operate. Such forward-looking statements are based on available current market material and management's expectations, beliefs, and forecasts concerning future events impacting us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in Item 1A. Risk Factors in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission ("SEC"). Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Please consult our public filings with the SEC, which are also available on our website at www.clarivate.com.

About Clarivate 
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-announces-full-redemption-of-remaining-100-million-senior-secured-notes-due-2026-and-provides-update-on-capital-allocation-activities-302675789.html

SOURCE Clarivate Plc

FAQ

What did Clarivate (CLVT) redeem on Jan 30, 2026?

Clarivate redeemed the remaining $100 million principal of its 4.50% senior secured notes due 2026. According to the company, the redemption paid 100% of principal plus accrued interest and was funded with cash on hand.

How many shares did Clarivate (CLVT) repurchase in 2025 and at what cost?

Clarivate repurchased approximately 56 million ordinary shares for $225 million during 2025. According to the company, ~21 million shares were repurchased for $75 million in Q4 2025 as part of its capital allocation.

How was the redemption of Clarivate's 2026 notes funded?

The redemption was funded with available cash on hand rather than new debt financing. According to the company, this funding choice supports efforts to simplify capital structure and reduce leverage.

What is the strategic purpose of Clarivate's 2025 share buybacks and redemption?

The actions aim to simplify capital structure, reduce debt, and return capital to shareholders while supporting long-term growth. According to the company, these moves enhance balance sheet strength and financial flexibility.

Will the full redemption of the 2026 notes affect Clarivate's interest expense?

Redeeming the 4.50% notes should reduce future interest expense associated with that debt issuance. According to the company, eliminating the remaining 2026 notes removes related coupon payments going forward.